Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HER-2/<i>neu</i>Oncogene Amplification by Fluorescence In Situ Hybridization in Epithelial Tumors of the Ovary

1 Mar 1999

Abstract excerpt

HER-2/neu gene amplification and protein overexpression have been associated with prognosis in breast, lung and prostate cancers but have not been extensively studied in ovarian carcinoma. For the study, we selected 5-micron-thick, formalin-fixed, paraffin-embedded tissue sections from 74 cases of ovarian epithelial tumors of low malignant potential and ovarian carcinoma. Tumors were graded and staged and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Biosensing Techniques and Applications
Share to Monoclonal and Polyclonal Antibodies Research
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10078105
DOI: 10.1093/ajcp/111.3.311

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HER-2/<i>neu</i>Oncogene Amplification by Fluorescence In Situ Hybridization in Epithelial Tumors of the OvaryPMID 10078105Read ↗

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.Semantic proximity Read ↗

HER-2/<i>neu</i> Analysis in Archival Tissue Samples of Human Breast Cancer: Comparison of Immunohistochemistry and Fluorescence In Situ HybridizationSemantic proximity Read ↗

HER‐2/ <i>neu</i> Signal Transduction in Human Breast and Ovarian CancerSemantic proximity Read ↗

Amplification of c‐erbB2 oncogeneSemantic proximity Read ↗

<i>HER2</i>Amplification in Gastroesophageal AdenocarcinomaSemantic proximity Read ↗

Gene amplification <i>CCNE1</i> is related to poor survival and potential therapeutic target in ovarian cancerSemantic proximity Read ↗

Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancersSemantic proximity Read ↗

Analysis of Gene Amplification and Prognostic Markers in Ovarian Cancer Using Comparative Genomic Hybridization for Microarrays and Immunohistochemical Analysis for Tissue MicroarraysSemantic proximity Read ↗

HER 2/neu expression and gene amplification in colon cancerSemantic proximity Read ↗

DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.Semantic proximity Read ↗

Lack of prognostic implications of HER‐2/<i>neu</i> abnormalities in 345 stage I nonsmall cell carcinomas (NSCLC) and 207 stage I–III neuroendocrine tumours (NET) of the lungSemantic proximity Read ↗

Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.